Evaluation of the Factors Associated with Reinfections towards SARS-CoV-2 Using a Case Control Design.

Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101606588 Publication Model: Electronic Cited Medium: Print ISSN: 2077-0383 (Print) Linking ISSN: 20770383 NLM ISO Abbreviation: J Clin Med Subsets: PubMed not MEDLINE

Original Publication: Basel, Switzerland : MDPI AG, [2012]-

Objective: The risk of reinfection with SARS-CoV-2 has been rapidly increased with the circulation of concerns about variants. So, the aim of our study was to evaluate the factors that increase the risk of this reinfection in healthcare workers compared to those who have never been positive and those who have had only one positivity.
Methods: A case-control study was carried out at the Teaching Hospital Policlinico Umberto I in Rome, Sapienza University of Rome, in the period between 6 March 2020 and 3 June 2022. Cases are healthcare workers who have developed a reinfection with the SARS-CoV-2 virus, while controls were either healthcare workers who tested positive once or those who have never tested positive for SARS-CoV-2.
Results: 134 cases and 267 controls were recruited. Female gender is associated with a higher odds of developing reinfection (OR: 2.42; 95% CI: 1.38-4.25). Moreover, moderate or high alcohol consumption is associated with higher odds of reinfection (OR: 1.49; 95% CI: 1.19-1.87). Diabetes is also associated with higher odds of reinfection (OR: 3.45; 95% CI: 1.41-8.46). Finally, subjects with increased red blood cell counts have higher odds of reinfection (OR: 1.69; 95% CI: 1.21-2.25).
Conclusion: From the prevention point of view, these findings indicate that particular attention should be paid to subjects with diabetes mellitus, women and alcoholic drinkers. These results could also suggest that contact tracing represents a fundamental approach model against the SARS-CoV-2 pandemic, together with the health information of participants.

Diabetes Metab Res Rev. 2007 Jan;23(1):3-13. (PMID: 16960917)
Infect Dis (Lond). 2021 May;53(5):315-324. (PMID: 33508989)
BMC Infect Dis. 2021 Sep 6;21(1):923. (PMID: 34488661)
Prim Care Diabetes. 2021 Feb;15(1):18-20. (PMID: 32800450)
Vaccines (Basel). 2022 Nov 08;10(11):. (PMID: 36366393)
Rev Invest Clin. 2022;74(4):175-180. (PMID: 36087938)
Lancet. 2021 Apr 17;397(10283):1459-1469. (PMID: 33844963)
Transl Res. 2014 Jan;163(1):53-63. (PMID: 23927943)
Lancet Diabetes Endocrinol. 2022 Mar;10(3):221-230. (PMID: 35114136)
J Med Virol. 2022 Jan;94(1):44-53. (PMID: 34411311)
Public Health. 2021 Apr;193:113-115. (PMID: 33774512)
J Leukoc Biol. 2017 Jul;102(1):41-55. (PMID: 28522597)
Eur J Epidemiol. 2020 Aug;35(8):763-773. (PMID: 32816244)
Glob Health Res Policy. 2022 Apr 29;7(1):12. (PMID: 35488305)
Emerg Infect Dis. 2021 Jul;27(7):1789-1794. (PMID: 33883059)
Sports Med Health Sci. 2021 Sep;3(3):181-182. (PMID: 34337552)
Trop Med Infect Dis. 2022 May 22;7(5):. (PMID: 35622708)
Curr Opin Psychiatry. 2021 Jul 1;34(4):376-385. (PMID: 34016817)
Biophys J. 2021 Jul 20;120(14):2838-2847. (PMID: 34087216)
Stem Cell Reports. 2021 Mar 9;16(3):428-436. (PMID: 33581053)
J Travel Med. 2021 Jun 1;28(4):. (PMID: 33834251)
Sci Rep. 2022 Dec 1;12(1):20763. (PMID: 36456577)
Sci Rep. 2020 Nov 26;10(1):20692. (PMID: 33244060)
Sci Rep. 2023 Jan 13;13(1):712. (PMID: 36639411)
Viruses. 2023 Apr 14;15(4):. (PMID: 37112949)

Keywords: SARS-CoV-2; case-control; contact tracing; reinfections

Date Created: 20230610 Latest Revision: 20230612

20231215

PMC10253296

10.3390/jcm12113861

37298055